Dermatologicals market size was valued at $19.974 billion in 2020, and is estimated to reach $59.309 billion by 2030, growing at a CAGR of 11.5% from 2021 to 2030. Dermatologicals are drugs that are used to treat or prevent conditions related to the skin. Moreover, dermatological preparations are applied directly to the skin by topical application or are administered through the parenteral route. Furthermore, dermatologicals are taken through oral route to cure skin conditions. Some of the conditions that are treated using dermatologicals include psoriasis, rosacea, acne, and dermatitis.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
AbbVie Inc. (Allergan PLC)., Amgen Inc., Galderma, GlaxoSmithKline Plc., Johnson & Johnson Services Inc, Leo Pharma A/S, Novartis AG, Organon & Co (Merck), Pfizer Inc., and Sun Pharmaceutical Industries Limited.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/3805
𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:
The COVID-19 outbreak is anticipated to have a positive impact on growth of the global dermatologicals market. The COVID-19 pandemic has stressed healthcare systems in the world. The dermatology practice is profoundly affected by the COVID-19 pandemic. A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Implementation of lockdown, owing to the COVID-19 outbreak resulted in decline in number of patient visits for the treatment during the pandemic. However, practice of teledermatology is being encouraged in the current scenario. Moreover, various skin disease such as urticarial, erythematous, atopic dermatitis, acne, rosacea, and purpuric are observed to be prevalent in patients suffering from COVID-19.
Furthermore, friction dermatitis, skin injury, hand irritation, and contact dermatitis, which are caused due to prolonged use of personal protective equipment are reported in majority of healthcare workers who are involved in care of patients suffering from COVID-19. Thus, upsurge in demand for dermatological products for the treatment of various skin diseases among COVID-19 patients positively impacted the growth of the market.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/3805
The global dermatologicals market is segmented into disease, type, route of administration, and region. On the basis of disease, the market is segregated into acne, dermatitis, psoriasis, skin cancer, rosacea, alopecia, and others. The psoriasis segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to rise in R&D activities related to manufacturing of dermatological products in the pharmaceutical sector and increase in prevalence of psoriasis .
Depending on type, the dermatologicals market is bifurcated into prescription-based drugs and over-the-counter drugs. The prescription-based drugs exhibited the highest growth in 2020, and is expected to lead during the forecast period, owing to increase in prevalence of skin diseases and development of dermatology drugs by the pharmaceutical industry. By route of administration, the market is categorized into topical administration, oral administration, and parenteral administration.
The topical administration segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in demand for topical administration, increase in number of U.S. FDA approval for drugs, and rise in R&D activities in the pharmaceutical sector.
𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
- By disease, the psoriasis segment was the highest contributor to the market in 2020.
- On the basis of type, the prescription drugs segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
- Depending on route of administration, the topical segment led the market in 2020.
- Region wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.